Elimination is a stated or aspirational goal for the NTDs targeted by preventive chemotherapy, but improved tools and a better understanding of the strategies to evaluate program impact are needed.
A common strategic framework would be useful to guide and monitor the progress of different programs toward elimination endpoints. Additionally, due to disease overlap, integrated approaches to assessing transmission and conducting surveillance are likely to yield programmatic efficiencies. Research will be supported to develop necessary strategies and tools, including diagnostics, to support decision making surrounding stopping mass drug administration (MDA) and post-MDA surveillance.
Key research projects include:
Assessing alternatives for strengthening the lymphatic filariasis (LF) Transmission Assessment Survey (TAS)
Validating new tools to support a coordinated approach to stopping MDA for LF and onchocerciasis
Defining alternative endpoint indicators for trachoma programs
Developing effective post-MDA surveillance strategies for LF, onchocerciasis, and trachoma
Defining objective markers of program success
Click here for a map of where the research projects are being implemented: http://www.ntdsupport.org/projects